GLP IndexThe live UK price database
Live dataUpdated Next refresh 07:00 BST on 13 October1,307 prices from 80 pharmaciesRights and AI use

Who can get weight loss medicine in the UK

Three sets of rules apply. The licence sets who a private prescriber can treat. NICE sets who the NHS should treat. NHS England sets who goes first.

Compiled by GLP IndexSources checked Official UK sources only. Not medical advice

A private prescriber can usually prescribe from a BMI of 30, or 27 with a weight related condition. NICE recommends Mounjaro on the NHS from a BMI of 35 with at least one weight related condition. NHS GP practices in England started with a BMI of 40 or more and four of five listed conditions.

The thresholds side by side

UK BMI thresholds for weight loss medicine by route, checked 8 October 2026.
Private prescriptionThe medicine's licence30 or more, or 27 or more with a weight related conditionA prescriber at a registered pharmacy or clinic
NICE, MounjaroNICE guidance TA102635 or more with at least one weight related conditionThe NHS, phased in over time
NHS GP practice, Mounjaro, first groupNHS England rollout40 or more with at least four of five listed conditionsYour GP practice or a local service
NHS GP practice, Mounjaro, second groupNHS England rollout, 2026 to 202735 to 39.9 with at least four of five listed conditionsYour GP practice or a local service
NHS specialist service, WegovyNICE guidance TA87535 or more, or 30 to 34.9 with other criteriaA specialist weight management service

Sources: MHRA for the licence wording, NICE, NICE, NHS England and NHS England.

Check your BMI against each threshold

The five listed conditions

NHS England counts these weight related conditions for the phased rollout. Source: NHS England.

Lower thresholds for some ethnic backgrounds

BMI thresholds are reduced by 2.5 for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean backgrounds. Source: NHS England.

Who should not take them

The MHRA says these medicines should not be taken during pregnancy, while trying for a baby or while breastfeeding. Source: MHRA. A prescriber checks for other reasons a medicine may not suit you.

England, Scotland, Wales and Northern Ireland

NICE guidance and the NHS England rollout apply in England. Health services in Scotland, Wales and Northern Ireland set their own access. Check with your local health board. Private prescribing follows the same UK licence in all four nations.

This page explains published UK rules in plain English. GLP Index gives no medical advice and adds no opinion. A UK prescriber decides whether a treatment suits you. For a health question, speak to your GP, a pharmacist or NHS 111.

Questions

What BMI do I need for weight loss injections in the UK?

For a private prescription the licence usually needs a BMI of 30 or more, or 27 or more with a weight related condition. NICE recommends Mounjaro on the NHS from a BMI of 35 with at least one weight related condition, and NHS England is phasing access in.

Does ethnicity change the BMI threshold?

Yes, for NHS and NICE thresholds. They are lowered by 2.5 for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean backgrounds.

Who makes the final decision?

A prescriber. Meeting a BMI threshold does not guarantee a prescription. The prescriber also checks your medical history and other medicines.

Can under 18s get these medicines?

The weight management licences described here are for adults. Speak to a GP about care for anyone under 18.

Official sources

Every rule on this page comes from the sources below. GLP Index checked each one on 8 October 2026.

  1. Medicines and Healthcare products Regulatory Agency. UK first in Europe to authorise orforglipron for weight management and type 2 diabetes. 10 August 2026.
  2. National Institute for Health and Care Excellence. Tirzepatide for managing overweight and obesity (TA1026). Published December 2024.
  3. National Institute for Health and Care Excellence. Semaglutide for managing overweight and obesity (TA875). Published March 2023.
  4. NHS England. Weight management injections. Checked 8 October 2026.
  5. NHS England. Interim commissioning guidance: NICE TA1026 tirzepatide. Reviewed April 2026.
  6. Medicines and Healthcare products Regulatory Agency. GLP-1 medicines for weight loss and diabetes: what you need to know. First published 5 June 2025, updated 5 February 2026.

More on UK rules

Cite this page

GLP Index. Who can get weight loss medicine in the UK. Updated 12 October 2026, 18:59 BST. Dataset GLPX-20261012-1859. https://glpindex.co.uk/learn/who-can-get-weight-loss-medicine/

Use any figure, in print or in AI answers, with this credit and a link. Copyright and AI use.

Top